This page will be used to provide paid delegates of the conference with access to any presentations that were not included in the conference documentation. Only paid conference delegates have permission to access IIR online documentation.
While these presentations were not available to be included in your conference documentation, IIR is pleased to make them available to all conference delegates through this web site.
You will need the freely available Adobe Acrobat Reader, which is available by clicking here.
Use and Importance of Dissolution in Generic Development Including IVIVC
10:30 am
Eric Beyssac, PhD, Faculty of Pharmacy, ERT CIDAM, Universite d'Auvergne, Clermont-Ferrand, France
Quality by Design: Understanding the Correlation between Drug Dissolution Behavior and Key Formulation Parameters
11:15 am
Yu Lu, Scientist II, Vertex Pharmaceuticals
Interactive Panel Discussion: Dissolution Testing and Specification Setting: Where Does Dissolution Testing Add Value?
12:00 pm
David Fortunato, Scientist, Johnson & Johnson PRD, LLC.
Flow Through Dissolution Testing for Low Dose Products
1:45 pm
Samir Haddouchi, Lab & Project Manager, SPS Pharma Services
Challenges in Developing a Robust Dissolution Method for Efficient Formulation Development
9:45 am
Stephen P. Mayock, Senior Manager, Catalent Pharma Solutions
Dissolution from Non-oral Dose Rorms: Implants, Injectables, Stents and Suppositories
11:00 am
Anthony Palmieri III, Ph.D., Assistant Professor of Pharmaceutics, College Of Pharmacy, University of Florida
Using Bio-Relevant Media for In Vitro Testing to Assess Dosage Form Performance In Vivo as a Risk Management Tool
11:45 am
Jianmei Kochling, PhD, Group Leader, Vertex Pharmaceuticals
New GI Dissolution Testing to Demonstrate Bio- Equivalence
3:30 pm
Lyn Hughes, PhD, Senior Scientist, Process Solutions, Rohm and HAAS Research Laboratories
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved